Valion Bio annual total assets
2021
2022
2023
2024
2025
Valion Bio Total Assets Growth & History (VBIO)
Valion Bio's total assets was $31.6M for fiscal 2025.
View full Valion Bio company overviewValion Bio annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $31.6M | $28.8M | +1026.01% |
| 2024 | 2024-12-31 | $2.8M | −$2.4M | −45.57% |
| 2023 | 2023-12-31 | $5.2M | −$718,000 | −12.22% |
| 2022 | 2022-12-31 | $5.9M | −$9.2M | −60.93% |
| 2021 | 2021-12-31 | $15.0M | — | — |
Valion Bio quarterly total assets
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $32.5M | $28.0M | +620.34% |
| Q1 2026 | 2026-03-31 | $38.2M | $34.4M | +911.78% |
| Q4 2025 | 2025-12-31 | $31.6M | $28.8M | +1026.01% |
| Q3 2025 | 2025-09-30 | $6.2M | $2.8M | +83.53% |
| Q2 2025 | 2025-06-30 | $4.5M | −$275,000 | −5.75% |
| Q1 2025 | 2025-03-31 | $3.8M | $491,000 | +14.94% |
| Q4 2024 | 2024-12-31 | $2.8M | −$2.4M | −45.57% |
| Q3 2024 | 2024-09-30 | $3.4M | −$3.6M | −51.56% |
| Q2 2024 | 2024-06-30 | $4.8M | $187,000 | +4.07% |
| Q1 2024 | 2024-03-31 | $3.3M | −$3.8M | −53.72% |
| Q4 2023 | 2023-12-31 | $5.2M | −$718,000 | −12.22% |
| Q3 2023 | 2023-09-30 | $7.0M | −$1.2M | −14.63% |
| Q2 2023 | 2023-06-30 | $4.6M | −$6.4M | −58.32% |
| Q1 2023 | 2023-03-31 | $7.1M | −$5.6M | −44.06% |
| Q4 2022 | 2022-12-31 | $5.9M | −$9.2M | −60.93% |
| Q3 2022 | 2022-09-30 | $8.2M | — | — |
| Q2 2022 | 2022-06-30 | $11.0M | — | — |
| Q1 2022 | 2022-03-31 | $12.7M | — | — |
| Q4 2021 | 2021-12-31 | $15.0M | — | — |
Valion Bio total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, Valion Bio's total assets increased from $15.0M to $31.6M, a change of $16.6M. The latest reported quarter, Q2 2026, shows $32.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Valion Bio source filings ↗